TipRanks
Brainstorm Cell Therapeutics (DE:GHD)
FRANKFURT:GHD
Germany Market
GHD
Brainstorm Cell Therapeutics
RESEARCH TOOLSreports

Brainstorm Cell Therapeutics (GHD) Income Statement

1 Followers

Brainstorm Cell Therapeutics Income Statement

Last quarter (Q2 2026), Brainstorm Cell Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Brainstorm Cell Therapeutics's net income was $-3.85M. See Brainstorm Cell Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Mar 24Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -240.00K$ -265.00K$ -285.00K$ -260.00K
Operating Expenses
$ 9.95M$ 11.69M$ 21.17M$ 24.82M$ 24.54M
Depreciation and Amortization
$ 199.00K$ 240.00K$ 265.00K$ 285.00K$ 260.00K
EBITDA
$ -9.75M$ -11.31M$ -16.93M$ -23.99M$ -24.28M
Operating Income
$ -9.95M$ -11.69M$ -21.44M$ -24.82M$ -24.54M
Other Income/Expenses
$ -354.00K$ 70.00K$ 4.25M$ 545.00K$ 82.00K
Pretax Income
$ -10.31M$ 11.62M$ -17.19M$ -24.28M$ -24.46M
Net Income
$ -10.31M$ 11.62M$ -17.19M$ -24.28M$ -24.46M
Per Share Metrics
Basic EPS
$ -1.11$ 2.19$ -4.48$ -9.93$ -10.09
Diluted EPS
$ -1.11$ 2.19$ -4.48$ -9.93$ -10.09
Weighted Average Shares Outstanding
 9.27M 5.31M 3.84M 2.45M 2.42M
Weighted Average Shares Outstanding (Diluted)
 9.27M 5.31M 3.84M 2.45M 2.42M
Currency in USD

Brainstorm Cell Therapeutics Earnings and Revenue History